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Desquamative inflammatory vaginitis (DIV) is a poorly understood chronic inflammatory vaginitis characterized by copious yellow discharge, vaginal irritation, and dyspareunia. Examination of the vaginal discharge shows a pH of at least 4.5, increased polymorphonuclear leukocytes (a ratio of polymorphonuclear leukocytes to epithelial cells \> 1:1), and many parabasal cells.[@bib1], [@bib2] It has been suggested that DIV could be a severe form of aerobic vaginitis.[@bib3] Vaginal cultures can grow group B *Streptococcus* species and/or *Escherichia coli* but are frequently negative for infectious pathogens.[@bib3] It has been reported that up to 27% of patients with DIV have multiple small erythematous macules on their ectocervix.[@bib2] This finding has been called "colpitis macularis" or "papular colpitis" and is similar to the ectocervical findings of a *Trichomonas vaginalis* infection.[@bib2], [@bib4] The diagnosis of DIV is one of exclusion, and other causes of vaginal inflammation must be ruled out, including *T vaginalis,* group A *Streptococcus* species, erosive lichen planus, atrophic vaginitis, seminal plasma hypersensitivity, and irritant vaginitis. Although the etiology of DIV is unknown, it has been postulated that estrogen deficiency, toxins from *Staphylococcus aureus,* or an immunologic process might be the cause.[@bib1]

Cervical ectropion is the presence of columnar cells on the ectocervix, which is normally composed of a squamous epithelium. Potential causes of ectropion include adolescent age, pregnancy, and hormonal contraceptives.[@bib5] Some clinicians believe ectropion could be a normal asymptomatic variant, whereas others believe it to be correlated with chronic cervicitis.[@bib5] The presence of the metaplastic columnar epithelium can manifest a myriad of symptoms including increased vaginal discharge, leukorrhea, postcoital bleeding, pelvic pain, recurrent cervicitis, and dyspareunia.[@bib5], [@bib6], [@bib7], [@bib8] Although the symptoms of ectropion overlap with DIV, it has not been reported as a cause of DIV.

Case report {#sec2}
===========

A 34-year-old G2P2002 woman presented to a center specializing in vulvovaginal disorders for evaluation of a 4-year history of persistent vulvovaginal pruritus, irritation, copious yellowish discharge, and introital dyspareunia. Before her presentation at the vulvovaginal clinic, she had been seen by multiple health care providers and had been treated with many courses of antimycotics and antibiotics including oral fluconazole, topical terconazole, topical and oral metronidazole, topical clindamycin, and topical nystatin. Unfortunately, she had no long-term improvement of her symptoms with these treatments.

On physical examination she was noted to have erythema and tenderness of her vulvar vestibule. Examination of her vaginal vault showed copious purulent vaginal discharge with erythema and tenderness of the vaginal mucosa, without lesions, ulcerations, erosions, or synechiae. The cervix was non-friable, without evidence of cervicitis, but cervical ectropion was noted ([Figure 1](#fig1){ref-type="fig"}). The pH of the vaginal discharge was 5.0 and light microscopy showed many leukocytes and parabasal cells. The vaginal culture obtained at presentation was negative for pathogens *T vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae,* and *Mycoplasma genitalium.*Figure 1Image of patient\'s cervix with ectopy before cryotherapy.

The patient was initially given the diagnosis of DIV, and because of her failed treatment with clindamycin, she was treated with intravaginal hydrocortisone as described by Sobel et al.[@bib9] Although she initially had complete resolution of her symptoms with this treatment, every time she stopped the intravaginal hydrocortisone, her symptoms recurred. Because the patient desired definitive treatment for her symptoms, she was offered cryotherapy (cryosurgery) as a treatment for her ectropion and as a possible treatment for her DIV.

Using a Graves speculum, the cervix was visualized and an appropriately sized cryo-tip and nitrous oxide were used to freeze the ectocervix for 90 seconds (LLCO~2~ System, Wallach Surgical Devices, Trumbull, CT, USA).[@bib6] Spontaneous thawing occurred within 60 seconds of the cessation of freezing. An additional freeze-thaw cycle was performed. The patient tolerated the procedure and had an uneventful postprocedure recovery.

The patient returned 9 weeks after cryosurgery and reported significant improvement in her vulvovaginal irritation and vaginal discharge since the procedure. She reported several weeks of clear, watery discharge after the procedure, but she denied any symptoms at the time of follow-up. At physical examination, the cervix was normal in appearance, with complete resolution of the ectropion ([Figure 2](#fig2){ref-type="fig"}). The vaginal mucosa was no longer erythematous or tender and there was minimal thin white discharge. Wet mount examination displayed very few leukocytes and no parabasal cells. Additional follow-up appointments, up to 34 months after her cryotherapy, confirmed persistent resolution of her ectropion ([Figure 3](#fig3){ref-type="fig"}) and DIV symptoms.Figure 2Image of patient\'s cervix 9 weeks after cryotherapy. The cervical ectropion has resolved.Figure 3Image of patient\'s cervix 34 months after cryotherapy.

Discussion {#sec3}
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DIV is a poorly understood chronic inflammatory vaginitis that accounts for 8% of patients with chronic vaginitis and is most common in perimenopausal women, although it is diagnosed in a wide age range.[@bib1], [@bib10] Therefore, our patient is somewhat unusual because she had DIV at 34 years of age. On average, women typically have DIV symptoms for 15 to 31 months before diagnosis.[@bib2], [@bib9] Although there have been no randomized controlled trials for the treatment of DIV, Sobel et al[@bib9] reported on a case series of 98 women who had high rates of improvement in symptoms with one of three treatments: vaginal clindamycin 2% cream, vaginal hydrocortisone 10% cream, or cortisone acetate 25 mg vaginal suppositories.[@bib9] They reported that 86% of women initially had improvement in symptoms with these treatments, but that 33% of patients had relapse within 6 weeks of treatment cessation and more than 58% of women required long-term maintenance therapy to remain asymptomatic. Sobel et al concluded that DIV is a chronic condition that requires long-term maintenance therapy in most patients.

The treatment goal for symptomatic ectropion is to destroy the glandular columnar epithelium, thereby inducing squamous metaplasia, leading to the resolution of vulvovaginal pruritus, irritation, yellowish discharge, and dyspareunia. Reported treatment modalities include laser ablation, microwave ablation, focused ultrasound, platelet-rich plasma injections, herbal therapies, and cryosurgery.[@bib6], [@bib7], [@bib11], [@bib12], [@bib13] Most studies have reported very high cure rates, such as a case series of 50 patients by Mohanty et al[@bib7] who reported a cure rate of 98% in patients who were treated with cryotherapy.

In conclusion, although it is common to find erythematous macules on the ectocervix of patients with DIV, the finding of concurrent cervical ectropion and DIV has not been reported. Our case illustrates the possibility that some patients with DIV can have an associated, although not necessarily causative, cervical ectropion. Therefore, given the minimal risks associated with cryotherapy, clinicians should consider this treatment in patients with concurrent DIV and ectropion in whom standard treatments for DIV have failed.
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